Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi
SUMMARYInvasive fungal diseases cause severe illness and death in immunocompromised patients. Antifungal use is increasingly common, as is fungal diagnostic testing. However, these efforts have not been guided by traditional stewardship efforts akin to those used for bacterial infections. Fungal diagnostic stewardship can have a significant impact on the care of vulnerable patients, including decreasing unnecessary testing while increasing appropriate testing and improving testing strategies to reduce diagnostic errors. In this review, we discuss the most frequently used fungal diagnostic assays for molds and dimorphic fungal infections, their diagnostic performance for these organisms in immunocompromised hosts, and strategies to improve diagnostic stewardship and ultimately patient outcomes.
Authors
- Kimberly E. Hanson (ORCID: https://orcid.org/0000-0001-9790-277X)
- Julie M. Steinbrink (ORCID: https://orcid.org/0000-0003-0771-3647)
- Daniel Friedman (ORCID: https://orcid.org/0000-0002-3442-7454)
- Hannah Imlay (ORCID: https://orcid.org/0000-0002-3429-4655)
- Barbara D. Alexander
- George R. Thompson
Institutions
- University of Utah (US)
- University of Michigan (US)
- University of Chicago (US)
- VA Salt Lake City Healthcare System (US)
- Duke Medical Center (US)
- University of California Davis Medical Center (US)
- University of California, Davis (US)
Publication Details
- Journal
- Clinical Microbiology Reviews
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1128/cmr.00242-25
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00